PEG-MGF
PEG-MGF (Pegylated Mechano Growth Factor) is a splice variant of IGF-1 that has been conjugated with Polyethylene Glycol (PEG). In laboratory research, the pegylation process is studied for its ability to increase the peptide’s half-life by reducing renal clearance. Investigations focus on its role in activating muscle satellite cells and promoting local tissue hypertrophy in response to mechanical stress models.
- Non-Approval: Not approved by regulatory agencies like the FDA for human clinical application or pharmaceutical use.
- Athletic Prohibition: Banned globally by the World Anti-Doping Agency (WADA) under the S2 category (Hormones and Related Substances).
- Risks: Potential risks identified in scientific literature include unknown long-term systemic consequences, potential promotion of atypical cell proliferation, and local injection-site reactions










Reviews
There are no reviews yet.